Description
Anti-Integrin alpha 4 beta 7 Antibody, Highly Galactosylated (BioBet-GA-324ZP) is a humanized IgG1, κ antibody against Integrin alpha 4 beta 7 which contains with a high level of galactosylation.
Antibody Indication
Ulcerative colitis (UC)
Classification
Therapeutic antibody; biobetter
Cooperation Seeking
Creative Biolabs is interested in collaborating with potential partners (include but not limit to major pharma or biotech firms) to further co-develop ADCC-enhanced Integrin alpha 4 beta 7 antibody. For commercial partners interested in our ADCC-enhanced therapeutic antibodies, Creative Biolabs welcomes collaboration. Here are two ways for your choice, and please contact us for more details.
1) Collaborate with us and co-develop the programs from discovery phase to IND enabling. Costs will be shared.
2) Become a licensed candidate of our programs.
Looking forward to cooperating with you in the near future.
Official Name
ITGA4
Full Name
Integrin Subunit Alpha 4
Background
The gene encodes a member of the integrin alpha chain family of proteins. Integrins are heterodimeric integral membrane proteins composed of an alpha chain and a beta chain that function in cell surface adhesion and signaling. The encoded preproprotein is proteolytically processed to generate light and heavy chains that comprise the alpha 4 subunit. This subunit associates with a beta 1 or beta 7 subunit to form an integrin that may play a role in cell motility and migration. This integrin is a therapeutic target for the treatment of multiple sclerosis, Crohn's disease and inflammatory bowel disease. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2015]
Alternative Names
Etrolizumab;1044758-60-2;rhuMAb Beta7;Anti-beta7;PRO145223;RG7413;ITGA4;integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor);CD49D;integrin alpha-4;CD49d;269C wild type;integrin alpha 4;integrin alpha-IV;VLA-4 subunit alpha;integrin alpha-
Gene ID
3676
UniProt ID
P13612
Cellular Localization
Membrane
Genecards
6140
Involvement in Disease
Its related pathways are Integrin Pathway and Degradation of the extracellular matrix.
Related Pathways
Integrin-4/ -1 (VLA-4) and -4/ -7 are receptors for fibronectin. They recognize one or more regions in the CS-1 and CS-5 regions of fibronectin. They are also receptors for VCAM1. Integrin alpha-4/ -1 recognizes the Q-I-D-S sequence in VCAM1. Integrin alpha-4/beta-7 is also a receptor for MADCAM1. It recognizes the L-D-T sequence in MADCAM1. On activated endothelial cells, the integrin volastin-4 triggers the homotypic aggregation of most volastin-4 positive leukocyte cell lines. It may also be involved in the interaction of cytolytic T cells with target cells. ITGA4: ITGB1 binds to fractalkine (CX3CL1), and may act as its co-receptor in cx3cr1-dependent fractalkine signaling (PubMed:23125415). ITGA4: ITGB1 binds to PLA2G2A through a site (2) different from the classical ligand binding site (1), thereby inducing a change in the conformation of the integrin and enhancing the binding of the ligand to site 1.
Field of research
Phosphorylation on Ser-1027 inhibits PXN binding.
Biologic Classification
Protein Based Therapies
Monoclonal antibody (mAb)
Antibody Isotype
IgG1, κ
Antibody Clone
BioBet-GA-324ZP
Description
Recombinant monoclonal antibody to integrin alpha 4 beta 7. Etrolizumab is a humanized monoclonal antibody designed for the treatment of inflammatory bowel disease.
Antibody Indication
Ulcerative colitis (UC)
